Pharmacokinetics of ertapenem in critically ill patients with acute renal failure undergoing extended daily dialysis

Abstract

In contrast to patients undergoing regular IHD, in which a dose reduction is required, our data suggest that in patients treated with EDD a standard dose of ertapenem (1 g/day), i.e. dose for patients without renal failure, is required to maintain adequate plasma drug levels.